Lexaria Bioscience (LEXX) Leases (2020 - 2025)
Historic Leases for Lexaria Bioscience (LEXX) over the last 6 years, with Q4 2025 value amounting to $99485.0.
- Lexaria Bioscience's Leases fell 2229.25% to $99485.0 in Q4 2025 from the same period last year, while for Nov 2025 it was $99485.0, marking a year-over-year decrease of 2229.25%. This contributed to the annual value of $106816.0 for FY2025, which is 2078.49% down from last year.
- Per Lexaria Bioscience's latest filing, its Leases stood at $99485.0 for Q4 2025, which was down 2229.25% from $106816.0 recorded in Q3 2025.
- Lexaria Bioscience's Leases' 5-year high stood at $178127.0 during Q2 2023, with a 5-year trough of $32047.0 in Q1 2023.
- For the 5-year period, Lexaria Bioscience's Leases averaged around $107163.6, with its median value being $108061.0 (2021).
- Its Leases has fluctuated over the past 5 years, first crashed by 5555.14% in 2023, then skyrocketed by 36805.32% in 2024.
- Lexaria Bioscience's Leases (Quarter) stood at $81656.0 in 2021, then crashed by 48.15% to $42340.0 in 2022, then skyrocketed by 269.78% to $156565.0 in 2023, then dropped by 18.23% to $128025.0 in 2024, then fell by 22.29% to $99485.0 in 2025.
- Its Leases was $99485.0 in Q4 2025, compared to $106816.0 in Q3 2025 and $114015.0 in Q2 2025.